tiprankstipranks
Trending News
More News >
Pharmaxis Ltd (AU:SNT)
ASX:SNT
Australian Market
Advertisement

Syntara Limited (SNT) Technical Analysis

Compare
15 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
2Neutral
8Bearish
Pharmaxis Ltd’s (SNT) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Pharmaxis Ltd is a Buy.
Pharmaxis Ltd’s (SNT) 20-Day exponential moving average is 0.03, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) 50-Day exponential moving average is 0.03, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.

Syntara Limited (SNT) Pivot Points

Nov 21, 2025, 10:48 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Fibonacci
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Syntara Limited (SNT) Moving Averages

Nov 21, 2025, 10:48 PM
Period
Simple
Exponential
MA5
0.03Neutral
0.03Sell
MA10
0.03Sell
0.03Sell
MA20
0.03Neutral
0.03Buy
MA50
0.03Buy
0.03Sell
MA100
0.04Sell
0.04Sell
MA200
0.05Sell
0.05Sell
Pharmaxis Ltd’s (SNT) 10-Day exponential moving average is 0.03, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (SNT) 100-Day exponential moving average is 0.04, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 50-day simple moving average is 0.03, creating a Buy signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 100-day simple moving average is 0.04, creating a Sell signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 200-day simple moving average is 0.05, creating a Sell signal.

Syntara Limited (SNT) Technical Indicators

Nov 21, 2025, 10:48 PM
Name
Value
Implied Action
RSI (14)
52.36
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
50.00
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
12.42
Buy
Williams %R
-50.00
Buy
CCI (14)
-36.36
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
76.12
Buy
ROC
0.00
Sell
Pharmaxis Ltd’s (SNT) Relative Strength Index (RSI) is 52.36, creating a Neutral signal.
Pharmaxis Ltd’s (SNT) Trend Strength Indicator (ADX) is 12.42, creating a Buy signal.
Pharmaxis Ltd’s (SNT) Commodity Channel Index (CCI) is -36.36, creating a Neutral signal.

FAQ

Is SNT a Buy, Hold, or Sell?
Based on SNT’s technical indicators, SNT is a Sell.
    What is SNT’s RSI (14)?
    SNT’s RSI (14) is 52.36, which suggests SNT is a Neutral.
      What is SNT’s MACD?
      SNT’s MACD is <0.01, which suggests SNT is a Buy.
        What is SNT’s 5-day moving average?
        SNT’s 5-day moving average is 0.03, which suggests SNT is a Neutral.
          What is SNT’s 20-day moving average?
          SNT 20-day moving average is 0.03, which suggests SNT is a Neutral.
            What is SNT’s 50-day moving average?
            SNT’s 50-day moving average is 0.03, which suggests SNT is a Buy.
              What is SNT’s 200-day moving average?
              SNT’s 200-day moving average is 0.05, which suggests SNT is a Sell.
                What is SNT’s Williams % R (14)?
                SNT’s Williams % R (14) is -50.00, which suggests SNT is a Buy.
                  What is SNT’s CCI (14)?
                  SNT’s CCI (14) is -36.36, which suggests SNT is a Neutral.
                    What is the share price of Pharmaxis Ltd?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis